person

BORIS ANTHONY B. C.

Country
Spain
Department
Servicio de Reumatología

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 34 partner sites.

Specializations

Neurological Disorders

The investigator concentrates on therapeutic strategies for epilepsy and related seizure phenotypes.

  • Focal seizures
  • Primary generalized tonic‑clonic seizures
  • Dravet syndrome
  • Tuberous sclerosis complex
  • Developmental and epileptic encephalopathies

Research emphasizes novel agents aimed at reducing seizure frequency and improving neurobehavioral outcomes.

Respiratory and Pulmonary Diseases

Focus is placed on disease‑modifying treatments for asthma and interstitial lung conditions such as idiopathic pulmonary fibrosis.

  • Asthma exacerbations
  • Idiopathic pulmonary fibrosis management

Efforts target symptom control, lung function preservation, and long‑term safety.

Cardiovascular & Thrombotic Conditions

Therapeutic development addresses rhythm disorders and clotting disorders such as atrial fibrillation and venous thromboembolism.

  • Atrial fibrillation management
  • Primary prevention of atherosclerotic cardiovascular disease
  • Cancer‑associated venous thromboembolism

Investigations aim to reduce thrombotic risk while minimizing bleeding complications.

Oncology

Engagement includes targeted and immunotherapeutic approaches for solid tumours, notably non‑small cell lung cancer and head‑and‑neck carcinoma.

  • ROS1‑positive lung cancer with brain metastasis
  • Metastatic squamous cell carcinoma of the head and neck
  • Previously untreated metastatic lung cancer

Objectives centre on enhancing response rates and extending survival.

Rheumatology & Autoimmune Disorders

Within the rheumatology service, the investigator explores biologic therapies for inflammatory arthritis, especially systemic juvenile idiopathic arthritis.

  • Biologic dosing in pediatric arthritis
  • Inflammatory disease activity modulation

Work seeks optimal dosing regimens and safety profiles for young patients.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.